bcr_patient_barcode	eastern_cancer_oncology_group	karnofsky_performance_score	age_at_initial_pathologic_diagnosis	race	gender	histological_type	tumor_status	treatment_outcome_first_course	treatment_outcome_first_course_v2	new_tumor_event_type	new_tumor_event_dx_days_to	history_of_neoadjuvant_treatment	radiation_therapy	postoperative_rx_tx	performance_status_scale_timing	OS	OS.time	DSS	DSS.time	DFI	DFI.time	PFI	PFI.time
TCGA-02-0001	NA	80	44	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	Yes	No	No	NA	1	358	1	358	NA	NA	1	137
TCGA-02-0003	NA	100	50	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	144	1	144	NA	NA	1	40
TCGA-02-0004	NA	80	59	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	345	1	345	NA	NA	1	314
TCGA-02-0006	NA	80	56	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	558	1	558	NA	NA	1	302
TCGA-02-0007	NA	80	40	WHITE	FEMALE	Treated_primary_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	Yes	No	No	NA	1	705	1	705	NA	NA	1	518
TCGA-02-0009	NA	80	61	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	322	1	322	NA	NA	1	264
TCGA-02-0010	NA	80	20	WHITE	FEMALE	Treated_primary_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	Yes	No	No	NA	1	1077	1	1077	NA	NA	1	351
TCGA-02-0011	NA	80	18	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	630	1	630	NA	NA	1	145
TCGA-02-0014	NA	100	25	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	2512	1	2512	NA	NA	1	2243
TCGA-02-0015	NA	80	50	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	627	1	627	NA	NA	1	456
TCGA-02-0016	NA	100	50	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	2648	1	2648	NA	NA	1	1699
TCGA-02-0021	NA	80	43	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	Yes	No	No	NA	1	2362	1	2362	NA	NA	1	255
TCGA-02-0023	NA	80	38	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	612	1	612	NA	NA	1	435
TCGA-02-0024	NA	100	35	WHITE	MALE	Treated_primary_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	Yes	No	No	NA	1	1615	1	1615	NA	NA	1	1401
TCGA-02-0025	NA	100	47	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	1300	1	1300	NA	NA	1	656
TCGA-02-0026	NA	80	27	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	748	1	748	NA	NA	1	462
TCGA-02-0027	NA	100	33	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	370	1	370	NA	NA	1	257
TCGA-02-0028	NA	100	39	WHITE	MALE	Treated_primary_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	Yes	No	No	NA	1	2755	1	2755	NA	NA	1	1921
TCGA-02-0033	NA	100	54	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	86	1	86	NA	NA	1	32
TCGA-02-0034	NA	80	60	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	430	1	430	NA	NA	1	386
TCGA-02-0037	NA	80	74	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	110	1	110	NA	NA	1	37
TCGA-02-0038	NA	80	48	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	326	1	326	NA	NA	1	239
TCGA-02-0039	NA	60	54	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	320	1	320	NA	NA	1	102
TCGA-02-0043	NA	80	54	WHITE	FEMALE	Treated_primary_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	Yes	No	No	NA	1	557	1	557	NA	NA	1	282
TCGA-02-0046	NA	60	61	BLACK_OR_AFRICAN_AMERICAN	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	209	1	209	NA	NA	1	195
TCGA-02-0047	NA	80	78	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	448	1	448	NA	NA	1	57
TCGA-02-0048	NA	NA	80	NA	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	98	NA	98	NA	NA	1	23
TCGA-02-0051	NA	100	43	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	459	1	459	NA	NA	1	89
TCGA-02-0052	NA	80	49	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	383	1	383	NA	NA	1	204
TCGA-02-0054	NA	80	44	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	199	1	199	NA	NA	1	72
TCGA-02-0055	NA	80	62	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	76	1	76	NA	NA	1	6
TCGA-02-0057	NA	80	66	WHITE	FEMALE	Treated_primary_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	Yes	No	No	NA	1	604	1	604	NA	NA	1	473
TCGA-02-0058	NA	80	28	WHITE	FEMALE	Treated_primary_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	254	1	254	NA	NA	1	172
TCGA-02-0059	NA	80	68	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	291	1	291	NA	NA	1	21
TCGA-02-0060	NA	80	66	ASIAN	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	183	1	183	NA	NA	1	183
TCGA-02-0064	NA	100	50	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	600	1	600	NA	NA	1	496
TCGA-02-0068	NA	80	57	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	804	1	804	NA	NA	1	175
TCGA-02-0069	NA	80	31	ASIAN	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	0	873	0	873	NA	NA	1	873
TCGA-02-0070	NA	80	70	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	0	762	0	762	NA	NA	1	762
TCGA-02-0071	NA	80	53	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	167	1	167	NA	NA	1	8
TCGA-02-0074	NA	80	68	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	310	1	310	NA	NA	1	154
TCGA-02-0075	NA	80	63	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	634	1	634	NA	NA	1	336
TCGA-02-0079	NA	80	57	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	829	1	829	NA	NA	1	798
TCGA-02-0080	NA	80	28	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	Yes	No	No	NA	1	2729	1	2729	NA	NA	1	2339
TCGA-02-0083	NA	80	59	WHITE	FEMALE	Treated_primary_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	Yes	No	No	NA	1	691	1	691	NA	NA	1	463
TCGA-02-0084	NA	80	36	WHITE	FEMALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	NA	1	384	NA	384	NA	NA	0	384
TCGA-02-0085	NA	80	63	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	1561	1	1561	NA	NA	1	976
TCGA-02-0086	NA	100	45	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	268	1	268	NA	NA	1	97
TCGA-02-0087	NA	80	27	WHITE	FEMALE	Untreated_primary_de_novo_GBM	NA	NA	NA	Recurrence	Yes	No	No	No	NA	0	1757	0	1757	NA	NA	1	1757
TCGA-02-0089	NA	100	52	WHITE	MALE	Treated_primary_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	Yes	No	No	NA	1	516	1	516	NA	NA	1	358
TCGA-02-0099	NA	80	46	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	Yes	No	No	NA	1	106	1	106	NA	NA	1	106
TCGA-02-0102	NA	100	42	WHITE	MALE	Treated_primary_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	Yes	No	No	NA	1	822	1	822	NA	NA	1	450
TCGA-02-0104	NA	80	29	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	1977	1	1977	NA	NA	1	1457
TCGA-02-0106	NA	80	54	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	355	1	355	NA	NA	1	196
TCGA-02-0107	NA	80	56	WHITE	MALE	Treated_primary_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	Yes	No	No	NA	1	537	1	537	NA	NA	1	146
TCGA-02-0111	NA	80	56	ASIAN	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	705	1	705	NA	NA	1	74
TCGA-02-0113	NA	100	43	WHITE	FEMALE	Treated_primary_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	Yes	No	No	NA	0	2818	0	2818	NA	NA	1	1560
TCGA-02-0114	NA	80	37	BLACK_OR_AFRICAN_AMERICAN	FEMALE	Treated_primary_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	Yes	No	No	NA	1	3041	1	3041	NA	NA	1	2296
TCGA-02-0115	NA	80	52	ASIAN	MALE	Treated_primary_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	476	1	476	NA	NA	1	91
TCGA-02-0116	NA	80	51	WHITE	MALE	Treated_primary_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	Yes	No	No	NA	1	1489	1	1489	NA	NA	1	1231
TCGA-02-0258	NA	NA	36	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	503	1	503	NA	NA	1	503
TCGA-02-0260	NA	NA	54	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	515	1	515	NA	NA	1	515
TCGA-02-0266	NA	NA	14	NA	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	539	1	539	NA	NA	1	293
TCGA-02-0269	NA	NA	68	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	327	1	327	NA	NA	1	99
TCGA-02-0271	NA	NA	26	NA	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	NA	1	440	NA	440	NA	NA	0	440
TCGA-02-0281	NA	NA	78	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	121	1	121	NA	NA	1	121
TCGA-02-0285	NA	NA	50	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	422	1	422	NA	NA	1	422
TCGA-02-0289	NA	80	57	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	432	1	432	NA	NA	1	245
TCGA-02-0290	NA	80	49	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	485	1	485	NA	NA	1	374
TCGA-02-0317	NA	80	40	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	372	1	372	NA	NA	1	238
TCGA-02-0321	NA	80	74	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	301	1	301	NA	NA	1	73
TCGA-02-0324	NA	80	69	NA	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	235	1	235	NA	NA	1	164
TCGA-02-0325	NA	80	61	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	323	1	323	NA	NA	1	284
TCGA-02-0326	NA	80	82	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	223	1	223	NA	NA	1	5
TCGA-02-0330	NA	80	51	BLACK_OR_AFRICAN_AMERICAN	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	484	1	484	NA	NA	1	120
TCGA-02-0332	NA	80	46	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	782	1	782	NA	NA	1	438
TCGA-02-0333	NA	NA	77	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	133	1	133	NA	NA	1	4
TCGA-02-0337	NA	80	48	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	764	1	764	NA	NA	1	691
TCGA-02-0338	NA	80	41	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	322	1	322	NA	NA	1	168
TCGA-02-0339	NA	80	67	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	377	1	377	NA	NA	1	148
TCGA-02-0422	NA	80	50	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	441	1	441	NA	NA	1	125
TCGA-02-0430	NA	100	67	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	321	1	321	NA	NA	1	321
TCGA-02-0432	NA	80	36	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	1433	1	1433	NA	NA	1	1053
TCGA-02-0439	1	80	70	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	20	1	20	NA	NA	1	13
TCGA-02-0440	NA	80	62	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	345	1	345	NA	NA	1	212
TCGA-02-0446	NA	80	61	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	282	1	282	NA	NA	1	15
TCGA-02-0451	NA	80	62	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	493	1	493	NA	NA	1	428
TCGA-02-0456	NA	60	67	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	102	1	102	NA	NA	1	12
TCGA-02-2466	NA	80	61	WHITE	MALE	Treated_primary_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	1	511	1	511	NA	NA	1	128
TCGA-02-2470	NA	60	57	WHITE	MALE	Treated_primary_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	Yes	No	No	Post-Adjuvant_Therapy	1	393	1	393	NA	NA	1	183
TCGA-02-2483	NA	80	43	ASIAN	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	0	466	0	466	NA	NA	0	466
TCGA-02-2485	NA	80	53	BLACK_OR_AFRICAN_AMERICAN	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	0	470	0	470	NA	NA	1	186
TCGA-02-2486	NA	80	64	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	618	1	618	NA	NA	1	618
TCGA-06-0119	NA	NA	81	WHITE	FEMALE	Glioblastoma_Multiforme_GBM	WITH_TUMOR	NA	NA	No	No	No	NO	YES	Pre-Adjuvant_Therapy	1	82	1	82	NA	NA	1	82
TCGA-06-0122	NA	NA	84	WHITE	FEMALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	NA	1	187	NA	187	NA	NA	0	187
TCGA-06-0124	NA	NA	67	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	620	1	620	NA	NA	1	620
TCGA-06-0125	NA	60	63	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	1448	1	1448	NA	NA	1	797
TCGA-06-0126	NA	60	86	WHITE	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	Preoperative	1	211	NA	211	NA	NA	0	211
TCGA-06-0127	NA	60	67	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	121	1	121	NA	NA	1	91
TCGA-06-0128	NA	80	66	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	691	1	691	NA	NA	1	190
TCGA-06-0129	NA	100	30	ASIAN	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	1024	1	1024	NA	NA	1	148
TCGA-06-0130	NA	80	54	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	394	1	394	NA	NA	1	244
TCGA-06-0132	NA	NA	49	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	771	1	771	NA	NA	1	482
TCGA-06-0133	NA	NA	64	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	435	1	435	NA	NA	1	78
TCGA-06-0137	NA	NA	63	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	812	1	812	NA	NA	1	487
TCGA-06-0138	NA	80	43	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	737	1	737	NA	NA	1	394
TCGA-06-0139	NA	60	40	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	362	1	362	NA	NA	1	152
TCGA-06-0140	NA	90	86	WHITE	MALE	Glioblastoma_Multiforme_GBM	WITH_TUMOR	NA	NA	No	No	No	NO	NO	Preoperative	1	6	1	6	NA	NA	1	6
TCGA-06-0141	NA	80	62	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	313	1	313	NA	NA	1	145
TCGA-06-0142	NA	NA	81	WHITE	MALE	Glioblastoma_Multiforme_GBM	WITH_TUMOR	NA	NA	No	No	No	NO	NO	NA	1	67	1	67	NA	NA	1	67
TCGA-06-0143	NA	60	58	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	357	1	357	NA	NA	1	265
TCGA-06-0145	NA	NA	53	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	71	1	71	NA	NA	1	71
TCGA-06-0146	NA	NA	33	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	611	1	611	NA	NA	1	530
TCGA-06-0147	NA	NA	51	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	541	1	541	NA	NA	1	92
TCGA-06-0148	NA	NA	76	BLACK_OR_AFRICAN_AMERICAN	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	307	1	307	NA	NA	1	189
TCGA-06-0149	NA	80	74	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	262	1	262	NA	NA	1	204
TCGA-06-0150	NA	NA	45	WHITE	MALE	Glioblastoma_Multiforme_GBM	WITH_TUMOR	NA	NA	No	No	No	YES	YES	NA	1	592	1	592	NA	NA	1	592
TCGA-06-0151	NA	70	32	WHITE	FEMALE	Glioblastoma_Multiforme_GBM	WITH_TUMOR	NA	NA	No	No	No	YES	YES	Post-Adjuvant_Therapy	1	1417	1	1417	NA	NA	1	1417
TCGA-06-0152	NA	NA	68	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	375	1	375	NA	NA	1	299
TCGA-06-0154	NA	100	54	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	424	1	424	NA	NA	1	208
TCGA-06-0155	NA	80	61	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	318	1	318	NA	NA	1	256
TCGA-06-0156	NA	NA	57	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	178	1	178	NA	NA	1	178
TCGA-06-0157	NA	40	63	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	97	1	97	NA	NA	1	97
TCGA-06-0158	NA	80	73	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	329	1	329	NA	NA	1	90
TCGA-06-0159	NA	90	74	WHITE	MALE	Glioblastoma_Multiforme_GBM	WITH_TUMOR	NA	NA	No	No	No	YES	YES	Post-Adjuvant_Therapy	1	287	1	287	NA	NA	1	287
TCGA-06-0160	NA	NA	56	WHITE	FEMALE	Glioblastoma_Multiforme_GBM	WITH_TUMOR	NA	NA	No	No	No	No	YES	NA	1	359	1	359	NA	NA	1	359
TCGA-06-0162	NA	60	47	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	104	1	104	NA	NA	1	104
TCGA-06-0164	NA	100	47	ASIAN	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	1731	1	1731	NA	NA	1	1428
TCGA-06-0165	NA	90	52	WHITE	MALE	Glioblastoma_Multiforme_GBM	WITH_TUMOR	NA	NA	No	No	No	YES	YES	Pre-Adjuvant_Therapy	1	324	1	324	NA	NA	1	324
TCGA-06-0166	NA	NA	51	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	178	1	178	NA	NA	1	66
TCGA-06-0167	NA	90	44	BLACK_OR_AFRICAN_AMERICAN	MALE	Glioblastoma_Multiforme_GBM	WITH_TUMOR	NA	NA	No	No	No	YES	YES	Pre-Adjuvant_Therapy	1	347	1	347	NA	NA	1	347
TCGA-06-0168	NA	100	59	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	598	1	598	NA	NA	1	461
TCGA-06-0169	NA	80	68	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	100	1	100	NA	NA	1	92
TCGA-06-0171	NA	100	65	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	399	1	399	NA	NA	1	117
TCGA-06-0173	NA	NA	72	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	136	1	136	NA	NA	1	136
TCGA-06-0174	NA	80	54	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	98	1	98	NA	NA	1	47
TCGA-06-0175	NA	100	69	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	123	1	123	NA	NA	1	39
TCGA-06-0176	NA	80	34	ASIAN	MALE	Untreated_primary_de_novo_GBM	TUMOR_FREE	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	0	2768	0	2768	NA	NA	1	41
TCGA-06-0177	NA	60	64	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	127	1	127	NA	NA	1	127
TCGA-06-0178	NA	NA	38	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	2681	1	2681	NA	NA	1	192
TCGA-06-0179	NA	60	64	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	616	1	616	NA	NA	1	250
TCGA-06-0182	NA	60	76	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	111	1	111	NA	NA	1	111
TCGA-06-0184	NA	80	63	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	Yes	No	No	No	Preoperative	1	2126	1	2126	NA	NA	1	1276
TCGA-06-0185	NA	100	54	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	0	2246	0	2246	NA	NA	1	711
TCGA-06-0187	NA	60	69	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Preoperative	1	828	1	828	NA	NA	1	531
TCGA-06-0188	NA	100	71	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	Yes	No	No	No	Preoperative	1	1356	1	1356	NA	NA	1	310
TCGA-06-0189	NA	NA	55	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	469	1	469	NA	NA	1	469
TCGA-06-0190	NA	80	62	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	317	1	317	NA	NA	1	88
TCGA-06-0192	NA	100	58	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Locoregional_Disease	Yes	No	No	No	Preoperative	1	1185	1	1185	NA	NA	1	648
TCGA-06-0194	NA	NA	37	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	142	1	142	NA	NA	1	125
TCGA-06-0195	NA	100	63	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	225	1	225	NA	NA	1	147
TCGA-06-0197	NA	NA	65	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	169	1	169	NA	NA	1	47
TCGA-06-0201	NA	NA	51	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	12	1	12	NA	NA	1	12
TCGA-06-0206	NA	NA	40	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	233	1	233	NA	NA	1	106
TCGA-06-0208	NA	80	52	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	256	1	256	NA	NA	1	149
TCGA-06-0209	NA	NA	76	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	232	1	232	NA	NA	1	232
TCGA-06-0210	NA	NA	72	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	225	1	225	NA	NA	1	67
TCGA-06-0211	NA	100	47	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	360	1	360	NA	NA	1	53
TCGA-06-0213	NA	NA	55	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	16	1	16	NA	NA	1	16
TCGA-06-0214	NA	100	66	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	457	1	457	NA	NA	1	48
TCGA-06-0216	NA	80	61	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	735	1	735	NA	NA	1	175
TCGA-06-0219	NA	NA	67	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	22	1	22	NA	NA	1	22
TCGA-06-0221	NA	100	31	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	603	1	603	NA	NA	1	260
TCGA-06-0237	NA	NA	75	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	415	1	415	NA	NA	1	415
TCGA-06-0238	NA	80	46	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	405	1	405	NA	NA	1	311
TCGA-06-0240	NA	90	57	WHITE	MALE	Glioblastoma_Multiforme_GBM	WITH_TUMOR	NA	NA	No	No	No	YES	YES	Preoperative	1	621	1	621	NA	NA	1	621
TCGA-06-0241	NA	100	65	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Preoperative	1	1481	1	1481	NA	NA	1	196
TCGA-06-0394	NA	NA	51	BLACK_OR_AFRICAN_AMERICAN	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	329	1	329	NA	NA	1	87
TCGA-06-0397	NA	NA	57	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	274	1	274	NA	NA	1	274
TCGA-06-0402	NA	NA	71	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	8	1	8	NA	NA	1	8
TCGA-06-0409	NA	NA	43	BLACK_OR_AFRICAN_AMERICAN	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	2201	1	2201	NA	NA	1	334
TCGA-06-0410	NA	NA	76	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	143	1	143	NA	NA	1	143
TCGA-06-0412	NA	NA	56	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	291	1	291	NA	NA	1	130
TCGA-06-0413	NA	NA	77	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	96	1	96	NA	NA	1	96
TCGA-06-0414	NA	NA	63	WHITE	MALE	Untreated_primary_de_novo_GBM	TUMOR_FREE	NA	NA	Recurrence	Yes	No	No	No	NA	1	1068	0	1068	NA	NA	1	1013
TCGA-06-0644	NA	80	71	BLACK_OR_AFRICAN_AMERICAN	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Preoperative	1	384	1	384	NA	NA	1	85
TCGA-06-0645	NA	NA	55	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	175	1	175	NA	NA	1	175
TCGA-06-0646	NA	80	60	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	175	1	175	NA	NA	1	90
TCGA-06-0648	NA	80	77	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	298	1	298	NA	NA	1	202
TCGA-06-0649	NA	NA	73	BLACK_OR_AFRICAN_AMERICAN	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	64	1	64	NA	NA	1	64
TCGA-06-0650	0	NA	39	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	717	1	717	NA	NA	1	351
TCGA-06-0686	NA	NA	53	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	432	1	432	NA	NA	1	160
TCGA-06-0743	NA	100	69	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	803	1	803	NA	NA	1	176
TCGA-06-0744	NA	80	66	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	Yes	No	No	No	Preoperative	1	1426	1	1426	NA	NA	1	1277
TCGA-06-0745	NA	80	59	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	239	1	239	NA	NA	1	92
TCGA-06-0747	NA	80	53	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	82	1	82	NA	NA	1	82
TCGA-06-0749	NA	NA	50	BLACK_OR_AFRICAN_AMERICAN	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	82	1	82	NA	NA	1	82
TCGA-06-0750	NA	80	43	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	28	1	28	NA	NA	1	28
TCGA-06-0875	NA	80	61	WHITE	FEMALE	Untreated_primary_de_novo_GBM	TUMOR_FREE	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	0	1322	0	1322	NA	NA	1	279
TCGA-06-0876	NA	80	72	BLACK_OR_AFRICAN_AMERICAN	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	Yes	No	No	No	Preoperative	0	1405	0	1405	NA	NA	1	424
TCGA-06-0877	NA	NA	78	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	0	204	0	204	NA	NA	0	204
TCGA-06-0878	NA	80	74	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Preoperative	0	218	0	218	NA	NA	1	66
TCGA-06-0879	NA	80	52	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	1229	1	1229	NA	NA	1	699
TCGA-06-0881	NA	80	50	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Preoperative	1	504	1	504	NA	NA	1	141
TCGA-06-0882	NA	60	30	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Preoperative	1	632	1	632	NA	NA	1	213
TCGA-06-0939	NA	80	79	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	814	1	814	NA	NA	1	329
TCGA-06-1084	NA	80	54	BLACK_OR_AFRICAN_AMERICAN	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	728	1	728	NA	NA	1	208
TCGA-06-1086	NA	80	42	BLACK_OR_AFRICAN_AMERICAN	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	208	1	208	NA	NA	1	208
TCGA-06-1087	NA	60	75	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Preoperative	1	123	1	123	NA	NA	1	109
TCGA-06-1800	NA	60	61	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Preoperative	1	815	1	815	NA	NA	1	750
TCGA-06-1801	NA	80	56	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Preoperative	1	360	1	360	NA	NA	1	232
TCGA-06-1802	NA	80	61	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Preoperative	1	466	1	466	NA	NA	1	81
TCGA-06-1804	NA	NA	81	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	414	1	414	NA	NA	1	414
TCGA-06-1805	NA	80	28	WHITE	FEMALE	Untreated_primary_de_novo_GBM	TUMOR_FREE	NA	NA	No	No	No	No	No	Preoperative	0	1031	0	1031	NA	NA	0	1031
TCGA-06-1806	NA	90	47	WHITE	MALE	Glioblastoma_Multiforme_GBM	WITH_TUMOR	Progressive_Disease	Uncomplete_Remission/Response	Progression_of_Disease	Yes	No	YES	YES	Pre-Adjuvant_Therapy	1	466	1	466	NA	NA	1	256
TCGA-06-2557	NA	40	76	BLACK_OR_AFRICAN_AMERICAN	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	33	1	33	NA	NA	1	33
TCGA-06-2558	NA	60	75	WHITE	FEMALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	Preoperative	1	380	NA	380	NA	NA	0	380
TCGA-06-2559	NA	60	83	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	150	1	150	NA	NA	1	150
TCGA-06-2561	NA	80	53	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Preoperative	1	537	1	537	NA	NA	1	78
TCGA-06-2562	NA	80	81	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	382	1	382	NA	NA	1	151
TCGA-06-2563	NA	80	72	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	Yes	No	No	No	Preoperative	0	932	0	932	NA	NA	1	554
TCGA-06-2564	NA	100	50	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Post-Adjuvant_Therapy	0	181	0	181	NA	NA	0	181
TCGA-06-2565	NA	100	59	ASIAN	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	506	1	506	NA	NA	1	178
TCGA-06-2566	NA	80	23	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	182	1	182	NA	NA	1	182
TCGA-06-2567	NA	80	65	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	133	1	133	NA	NA	1	133
TCGA-06-2569	NA	80	24	BLACK_OR_AFRICAN_AMERICAN	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	0	13	0	13	NA	NA	0	13
TCGA-06-2570	NA	100	21	WHITE	FEMALE	Untreated_primary_de_novo_GBM	TUMOR_FREE	NA	NA	No	No	No	No	No	Preoperative	0	958	0	958	NA	NA	0	958
TCGA-06-5408	NA	80	54	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	357	1	357	NA	NA	1	158
TCGA-06-5410	NA	60	72	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	108	1	108	NA	NA	1	108
TCGA-06-5411	NA	80	51	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	254	1	254	NA	NA	1	214
TCGA-06-5412	NA	80	78	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	138	1	138	NA	NA	1	88
TCGA-06-5413	NA	60	67	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	0	268	0	268	NA	NA	1	195
TCGA-06-5414	NA	80	61	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	0	273	0	273	NA	NA	1	167
TCGA-06-5415	NA	100	60	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	0	260	0	260	NA	NA	0	260
TCGA-06-5416	NA	80	23	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	0	204	0	204	NA	NA	0	204
TCGA-06-5417	NA	80	45	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	0	155	0	155	NA	NA	0	155
TCGA-06-5418	NA	60	75	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	83	1	83	NA	NA	1	83
TCGA-06-5856	NA	NA	58	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	114	1	114	NA	NA	1	114
TCGA-06-5858	0	100	45	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	0	187	0	187	NA	NA	1	97
TCGA-06-5859	NA	40	63	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Post-Adjuvant_Therapy	0	139	0	139	NA	NA	0	139
TCGA-06-6388	NA	80	64	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	159	1	159	NA	NA	1	85
TCGA-06-6389	NA	100	49	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	0	237	0	237	NA	NA	0	237
TCGA-06-6390	NA	80	58	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	164	1	164	NA	NA	1	164
TCGA-06-6391	1	NA	44	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	45	1	45	NA	NA	1	45
TCGA-06-6693	NA	NA	64	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	3667	1	3667	NA	NA	1	3667
TCGA-06-6694	NA	NA	76	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	224	1	224	NA	NA	1	224
TCGA-06-6695	NA	40	64	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	0	253	0	253	NA	NA	1	133
TCGA-06-6697	NA	80	65	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	0	391	0	391	NA	NA	1	306
TCGA-06-6698	NA	NA	53	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	0	145	0	145	NA	NA	0	145
TCGA-06-6699	NA	NA	58	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	0	47	0	47	NA	NA	0	47
TCGA-06-6700	NA	100	76	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	0	145	0	145	NA	NA	0	145
TCGA-06-6701	NA	NA	60	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	0	151	0	151	NA	NA	0	151
TCGA-06-A5U0	NA	90	21	BLACK_OR_AFRICAN_AMERICAN	FEMALE	Glioblastoma_Multiforme_GBM	WITH_TUMOR	Progressive_Disease	Uncomplete_Remission/Response	Progression_of_Disease	Yes	No	YES	YES	Post-Adjuvant_Therapy	0	815	0	815	NA	NA	1	100
TCGA-06-A5U1	NA	NA	78	BLACK_OR_AFRICAN_AMERICAN	FEMALE	Glioblastoma_Multiforme_GBM	WITH_TUMOR	Progressive_Disease	Uncomplete_Remission/Response	No	No	No	NO	NO	NA	1	57	1	57	NA	NA	1	57
TCGA-06-A6S0	NA	NA	79	BLACK_OR_AFRICAN_AMERICAN	MALE	Glioblastoma_Multiforme_GBM	WITH_TUMOR	Stable_Disease	Uncomplete_Remission/Response	No	No	No	YES	NO	NA	1	95	1	95	NA	NA	1	95
TCGA-06-A6S1	NA	60	53	BLACK_OR_AFRICAN_AMERICAN	FEMALE	Glioblastoma_Multiforme_GBM	WITH_TUMOR	Progressive_Disease	Uncomplete_Remission/Response	Progression_of_Disease	Yes	No	YES	YES	Pre-Adjuvant_Therapy	1	78	1	78	NA	NA	1	46
TCGA-06-A7TK	NA	70	64	BLACK_OR_AFRICAN_AMERICAN	MALE	Glioblastoma_Multiforme_GBM	WITH_TUMOR	Progressive_Disease	Uncomplete_Remission/Response	Progression_of_Disease	Yes	No	YES	YES	Pre-Adjuvant_Therapy	1	444	1	444	NA	NA	1	342
TCGA-06-A7TL	NA	100	30	BLACK_OR_AFRICAN_AMERICAN	FEMALE	Glioblastoma_Multiforme_GBM	WITH_TUMOR	Stable_Disease	Uncomplete_Remission/Response	Progression_of_Disease	Yes	No	YES	YES	Preoperative	0	539	0	539	NA	NA	1	188
TCGA-08-0244	NA	80	62	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Other	1	690	1	690	NA	NA	1	484
TCGA-08-0245	NA	80	31	BLACK_OR_AFRICAN_AMERICAN	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	1	1151	1	1151	NA	NA	1	463
TCGA-08-0246	NA	80	57	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Other	1	127	1	127	NA	NA	1	103
TCGA-08-0344	NA	80	66	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Other	1	3524	1	3524	NA	NA	1	1880
TCGA-08-0345	NA	60	71	NA	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	53	1	53	NA	NA	1	53
TCGA-08-0346	NA	80	69	NA	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	256	1	256	NA	NA	1	75
TCGA-08-0347	NA	100	50	NA	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Other	1	782	1	782	NA	NA	1	59
TCGA-08-0348	NA	80	63	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Other	1	370	1	370	NA	NA	1	198
TCGA-08-0349	NA	NA	46	NA	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	298	1	298	NA	NA	1	93
TCGA-08-0350	NA	80	32	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Post-Adjuvant_Therapy	1	889	1	889	NA	NA	1	439
TCGA-08-0351	NA	80	40	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Other	1	1987	1	1987	NA	NA	1	1542
TCGA-08-0352	NA	NA	79	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	39	1	39	NA	NA	1	39
TCGA-08-0353	NA	80	58	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	1	256	1	256	NA	NA	1	164
TCGA-08-0354	NA	60	52	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	1	546	1	546	NA	NA	1	253
TCGA-08-0355	NA	100	30	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Other	1	747	1	747	NA	NA	1	519
TCGA-08-0356	NA	80	59	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	946	1	946	NA	NA	1	447
TCGA-08-0357	NA	80	49	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Other	1	1143	1	1143	NA	NA	1	155
TCGA-08-0358	NA	80	50	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	678	1	678	NA	NA	1	264
TCGA-08-0359	NA	NA	59	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	103	1	103	NA	NA	1	103
TCGA-08-0360	NA	80	76	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	468	1	468	NA	NA	1	112
TCGA-08-0373	NA	NA	69	NA	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	134	1	134	NA	NA	1	134
TCGA-08-0375	NA	100	51	NA	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Post-Adjuvant_Therapy	1	372	1	372	NA	NA	1	161
TCGA-08-0380	NA	80	74	NA	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	454	1	454	NA	NA	1	151
TCGA-08-0385	NA	60	71	NA	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	82	1	82	NA	NA	1	82
TCGA-08-0386	NA	80	74	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	548	1	548	NA	NA	1	427
TCGA-08-0389	NA	80	59	NA	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Other	1	467	1	467	NA	NA	1	467
TCGA-08-0390	NA	60	69	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Post-Adjuvant_Therapy	1	425	1	425	NA	NA	1	425
TCGA-08-0392	NA	NA	60	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	22	1	22	NA	NA	1	22
TCGA-08-0509	NA	60	63	BLACK_OR_AFRICAN_AMERICAN	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	382	1	382	NA	NA	1	382
TCGA-08-0510	NA	80	75	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Other	1	130	1	130	NA	NA	1	90
TCGA-08-0511	NA	80	69	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Other	1	235	1	235	NA	NA	1	235
TCGA-08-0512	NA	100	48	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	1282	1	1282	NA	NA	1	231
TCGA-08-0514	NA	40	69	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Post-Adjuvant_Therapy	1	337	1	337	NA	NA	1	337
TCGA-08-0516	NA	NA	14	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	596	1	596	NA	NA	1	40
TCGA-08-0517	NA	80	34	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	Yes	No	No	Post-Adjuvant_Therapy	1	1785	1	1785	NA	NA	1	1024
TCGA-08-0518	NA	80	60	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	588	1	588	NA	NA	1	134
TCGA-08-0520	NA	NA	70	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	327	1	327	NA	NA	1	105
TCGA-08-0521	NA	60	17	BLACK_OR_AFRICAN_AMERICAN	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	1	146	1	146	NA	NA	1	125
TCGA-08-0522	NA	80	61	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Other	1	635	1	635	NA	NA	1	266
TCGA-08-0524	NA	80	17	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Other	1	221	1	221	NA	NA	1	61
TCGA-08-0525	NA	80	52	NA	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	Yes	No	No	Other	1	486	1	486	NA	NA	1	343
TCGA-08-0529	NA	80	56	NA	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	560	1	560	NA	NA	1	328
TCGA-08-0531	NA	80	64	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	230	1	230	NA	NA	1	230
TCGA-12-0615	NA	60	78	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	467	1	467	NA	NA	1	160
TCGA-12-0616	NA	100	36	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	448	1	448	NA	NA	1	398
TCGA-12-0618	NA	60	49	WHITE	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	395	NA	395	NA	NA	0	395
TCGA-12-0619	NA	80	60	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	1062	1	1062	NA	NA	1	203
TCGA-12-0620	NA	100	57	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	318	1	318	NA	NA	1	318
TCGA-12-0653	NA	60	65	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	320	1	320	NA	NA	1	267
TCGA-12-0654	NA	NA	48	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	231	1	231	NA	NA	1	216
TCGA-12-0656	NA	80	48	BLACK_OR_AFRICAN_AMERICAN	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	1	2883	1	2883	NA	NA	1	1467
TCGA-12-0657	NA	NA	69	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	3	1	3	NA	NA	1	3
TCGA-12-0662	NA	80	51	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	1	1161	1	1161	NA	NA	1	600
TCGA-12-0670	NA	100	60	WHITE	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	790	NA	790	NA	NA	1	379
TCGA-12-0688	NA	100	74	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	1	811	1	811	NA	NA	1	228
TCGA-12-0691	NA	100	63	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	1	369	1	369	NA	NA	1	98
TCGA-12-0692	NA	60	75	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	111	1	111	NA	NA	1	35
TCGA-12-0703	NA	80	46	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	1	620	1	620	NA	NA	1	208
TCGA-12-0707	NA	NA	55	WHITE	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	NA	1	864	NA	864	NA	NA	0	864
TCGA-12-0769	NA	100	52	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	458	1	458	NA	NA	1	378
TCGA-12-0772	NA	80	46	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	1638	1	1638	NA	NA	1	607
TCGA-12-0773	NA	100	24	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	1315	1	1315	NA	NA	1	725
TCGA-12-0775	NA	60	75	BLACK_OR_AFRICAN_AMERICAN	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	1	232	1	232	NA	NA	1	94
TCGA-12-0776	NA	80	52	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	296	1	296	NA	NA	1	127
TCGA-12-0778	NA	80	53	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	1	454	1	454	NA	NA	1	232
TCGA-12-0780	NA	80	51	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	452	1	452	NA	NA	1	91
TCGA-12-0818	NA	NA	45	WHITE	FEMALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	NA	1	2791	NA	2791	NA	NA	0	2791
TCGA-12-0819	NA	60	49	BLACK_OR_AFRICAN_AMERICAN	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Post-Adjuvant_Therapy	1	754	1	754	NA	NA	1	428
TCGA-12-0820	NA	100	40	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Preoperative	1	562	1	562	NA	NA	1	272
TCGA-12-0821	NA	60	62	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Post-Adjuvant_Therapy	1	323	1	323	NA	NA	1	259
TCGA-12-0822	NA	80	46	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Post-Adjuvant_Therapy	1	715	1	715	NA	NA	1	91
TCGA-12-0826	NA	NA	38	WHITE	FEMALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	NA	1	845	NA	845	NA	NA	0	845
TCGA-12-0827	NA	100	38	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Post-Adjuvant_Therapy	1	1179	1	1179	NA	NA	1	1179
TCGA-12-0828	NA	60	57	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	272	1	272	NA	NA	1	13
TCGA-12-0829	NA	80	75	BLACK_OR_AFRICAN_AMERICAN	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	626	1	626	NA	NA	1	473
TCGA-12-1088	NA	80	53	WHITE	FEMALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	3881	NA	3881	NA	NA	0	3881
TCGA-12-1089	NA	NA	64	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	177	1	177	NA	NA	1	177
TCGA-12-1090	NA	60	58	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Post-Adjuvant_Therapy	1	231	1	231	NA	NA	1	231
TCGA-12-1091	NA	80	10	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	1010	1	1010	NA	NA	1	56
TCGA-12-1092	NA	80	58	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	661	1	661	NA	NA	1	637
TCGA-12-1093	NA	80	66	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	486	1	486	NA	NA	1	322
TCGA-12-1094	NA	100	56	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	372	1	372	NA	NA	1	186
TCGA-12-1095	NA	100	65	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	482	1	482	NA	NA	1	96
TCGA-12-1096	NA	80	55	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	277	1	277	NA	NA	1	270
TCGA-12-1097	NA	100	61	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	442	1	442	NA	NA	1	166
TCGA-12-1098	NA	60	75	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	121	1	121	NA	NA	1	93
TCGA-12-1099	NA	80	68	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	126	1	126	NA	NA	1	62
TCGA-12-1597	NA	80	62	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	1	675	1	675	NA	NA	1	180
TCGA-12-1598	NA	NA	75	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	476	1	476	NA	NA	1	476
TCGA-12-1599	NA	80	47	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	781	1	781	NA	NA	1	89
TCGA-12-1600	NA	80	86	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	1	448	1	448	NA	NA	1	404
TCGA-12-1602	NA	60	58	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	206	1	206	NA	NA	1	140
TCGA-12-3644	NA	60	47	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	1	1818	1	1818	NA	NA	1	1142
TCGA-12-3646	NA	80	59	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	1339	1	1339	NA	NA	1	1315
TCGA-12-3648	NA	80	61	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	1	819	1	819	NA	NA	1	86
TCGA-12-3649	NA	80	76	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	463	1	463	NA	NA	1	351
TCGA-12-3650	NA	80	46	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	333	1	333	NA	NA	1	239
TCGA-12-3651	NA	80	77	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	386	1	386	NA	NA	1	358
TCGA-12-3652	NA	80	60	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	1062	1	1062	NA	NA	1	203
TCGA-12-3653	NA	80	34	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	442	1	442	NA	NA	1	224
TCGA-12-5295	1	NA	60	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	454	1	454	NA	NA	1	399
TCGA-12-5299	NA	80	56	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	98	1	98	NA	NA	1	98
TCGA-12-5301	NA	80	59	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	62	1	62	NA	NA	1	62
TCGA-14-0736	NA	100	49	BLACK_OR_AFRICAN_AMERICAN	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	460	1	460	NA	NA	1	128
TCGA-14-0740	NA	60	70	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	364	1	364	NA	NA	1	364
TCGA-14-0781	NA	NA	49	BLACK_OR_AFRICAN_AMERICAN	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	29	1	29	NA	NA	1	29
TCGA-14-0783	NA	80	36	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	189	1	189	NA	NA	1	189
TCGA-14-0786	NA	80	50	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	701	1	701	NA	NA	1	127
TCGA-14-0787	NA	60	69	ASIAN	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	Post-Adjuvant_Therapy	1	68	NA	68	NA	NA	0	68
TCGA-14-0789	NA	40	54	WHITE	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	1	342	NA	342	NA	NA	1	105
TCGA-14-0790	NA	60	64	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Post-Adjuvant_Therapy	1	419	1	419	NA	NA	1	419
TCGA-14-0812	NA	40	65	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Post-Adjuvant_Therapy	1	99	1	99	NA	NA	1	99
TCGA-14-0813	NA	60	78	WHITE	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	Other	1	41	NA	41	NA	NA	0	41
TCGA-14-0817	NA	60	69	WHITE	FEMALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	Other	1	164	NA	164	NA	NA	0	164
TCGA-14-0862	NA	40	60	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Other	1	88	1	88	NA	NA	1	88
TCGA-14-0865	NA	60	67	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	502	1	502	NA	NA	1	215
TCGA-14-0866	NA	80	55	WHITE	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	801	NA	801	NA	NA	1	97
TCGA-14-0867	NA	60	67	WHITE	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	Other	1	62	NA	62	NA	NA	0	62
TCGA-14-0871	NA	60	74	WHITE	FEMALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	Post-Adjuvant_Therapy	1	880	NA	880	NA	NA	0	880
TCGA-14-1034	NA	60	60	NA	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	485	1	485	NA	NA	1	282
TCGA-14-1037	NA	60	66	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	587	1	587	NA	NA	1	326
TCGA-14-1043	NA	40	61	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	24	1	24	NA	NA	1	24
TCGA-14-1395	NA	80	52	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	42	1	42	NA	NA	1	42
TCGA-14-1396	NA	60	78	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Other	1	34	1	34	NA	NA	1	34
TCGA-14-1401	NA	80	54	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Other	1	114	1	114	NA	NA	1	114
TCGA-14-1402	NA	80	58	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	975	1	975	NA	NA	1	333
TCGA-14-1450	NA	80	57	BLACK_OR_AFRICAN_AMERICAN	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	0	1788	0	1788	NA	NA	1	826
TCGA-14-1451	NA	80	39	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	703	1	703	NA	NA	1	19
TCGA-14-1452	NA	80	60	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Post-Adjuvant_Therapy	1	216	1	216	NA	NA	1	172
TCGA-14-1453	NA	60	69	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Other	1	35	1	35	NA	NA	1	35
TCGA-14-1454	NA	60	54	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Other	1	918	1	918	NA	NA	1	291
TCGA-14-1455	NA	NA	61	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	28	1	28	NA	NA	1	28
TCGA-14-1456	NA	80	23	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	0	1246	0	1246	NA	NA	1	98
TCGA-14-1458	NA	80	54	WHITE	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	203	NA	203	NA	NA	1	81
TCGA-14-1459	NA	100	63	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	378	1	378	NA	NA	1	275
TCGA-14-1794	NA	NA	59	NA	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	30	1	30	NA	NA	1	30
TCGA-14-1795	NA	60	66	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Post-Adjuvant_Therapy	1	60	1	60	NA	NA	1	60
TCGA-14-1821	NA	80	31	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	541	1	541	NA	NA	1	331
TCGA-14-1823	NA	80	58	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	543	1	543	NA	NA	1	140
TCGA-14-1825	NA	80	70	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	232	1	232	NA	NA	1	82
TCGA-14-1827	NA	100	51	WHITE	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	179	NA	179	NA	NA	0	179
TCGA-14-1829	NA	60	57	BLACK_OR_AFRICAN_AMERICAN	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	0	218	0	218	NA	NA	0	218
TCGA-14-2554	NA	60	52	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	532	1	532	NA	NA	1	532
TCGA-14-2555	NA	80	44	WHITE	FEMALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	0	242	0	242	NA	NA	0	242
TCGA-14-3476	NA	NA	74	WHITE	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	12	NA	12	NA	NA	1	9
TCGA-14-3477	NA	80	38	BLACK_OR_AFRICAN_AMERICAN	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	0	115	0	115	NA	NA	0	115
TCGA-14-4157	NA	60	40	BLACK_OR_AFRICAN_AMERICAN	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	0	104	0	104	NA	NA	1	96
TCGA-15-0742	NA	80	65	WHITE	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	419	NA	419	NA	NA	1	232
TCGA-15-1444	NA	NA	21	WHITE	MALE	Glioblastoma_Multiforme_GBM	WITH_TUMOR	Complete_Remission/Response	Complete_Remission/Response	Progression_of_Disease	Yes	No	YES	YES	NA	1	1537	1	1537	1	1550	1	1550
TCGA-15-1446	1	80	55	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	0	581	0	581	NA	NA	1	443
TCGA-15-1447	1	80	36	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Preoperative	0	1618	0	1618	NA	NA	1	340
TCGA-15-1449	2	60	65	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	404	1	404	NA	NA	1	74
TCGA-16-0846	NA	NA	85	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	119	1	119	NA	NA	1	119
TCGA-16-0848	NA	NA	57	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	535	1	535	NA	NA	1	129
TCGA-16-0849	NA	NA	54	WHITE	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	NA	0	793	0	793	NA	NA	0	793
TCGA-16-0850	NA	NA	52	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	498	1	498	NA	NA	1	83
TCGA-16-0861	NA	NA	65	WHITE	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	Recurrence	Yes	No	No	No	NA	0	131	NA	131	NA	NA	1	94
TCGA-16-1045	NA	NA	49	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	883	1	883	NA	NA	1	654
TCGA-16-1047	NA	NA	66	NA	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	139	1	139	NA	NA	1	25
TCGA-16-1055	NA	NA	48	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	313	1	313	NA	NA	1	288
TCGA-16-1056	NA	NA	55	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	426	1	426	NA	NA	1	239
TCGA-16-1060	NA	NA	70	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	278	1	278	NA	NA	1	111
TCGA-16-1062	NA	NA	57	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	646	1	646	NA	NA	1	518
TCGA-16-1063	NA	NA	72	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	425	1	425	NA	NA	1	369
TCGA-16-1460	NA	NA	36	WHITE	FEMALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	NA	0	195	0	195	NA	NA	0	195
TCGA-19-0955	NA	NA	71	ASIAN	MALE	Untreated_primary_de_novo_GBM	TUMOR_FREE	NA	NA	No	No	No	No	No	NA	0	358	0	358	NA	NA	0	358
TCGA-19-0957	1	NA	48	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Post-Adjuvant_Therapy	1	666	1	666	NA	NA	1	50
TCGA-19-0960	NA	60	83	WHITE	FEMALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	Post-Adjuvant_Therapy	0	262	0	262	NA	NA	0	262
TCGA-19-0962	NA	40	77	WHITE	FEMALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	20	NA	20	NA	NA	0	20
TCGA-19-0963	NA	NA	61	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	434	1	434	NA	NA	1	310
TCGA-19-0964	NA	60	70	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Post-Adjuvant_Therapy	0	103	0	103	NA	NA	0	103
TCGA-19-1385	2	NA	69	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Post-Adjuvant_Therapy	1	327	1	327	NA	NA	1	177
TCGA-19-1386	NA	80	51	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Post-Adjuvant_Therapy	1	276	1	276	NA	NA	1	237
TCGA-19-1387	NA	60	81	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Post-Adjuvant_Therapy	0	181	0	181	NA	NA	1	79
TCGA-19-1388	3	NA	58	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	1	394	1	394	NA	NA	1	148
TCGA-19-1389	NA	80	51	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	141	1	141	NA	NA	1	81
TCGA-19-1390	NA	60	63	WHITE	FEMALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	772	NA	772	NA	NA	0	772
TCGA-19-1392	NA	60	72	WHITE	FEMALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	111	NA	111	NA	NA	0	111
TCGA-19-1786	NA	40	64	ASIAN	FEMALE	Untreated_primary_de_novo_GBM	TUMOR_FREE	NA	NA	No	No	No	No	No	NA	0	218	0	218	NA	NA	0	218
TCGA-19-1787	NA	80	48	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	385	1	385	NA	NA	1	308
TCGA-19-1788	NA	60	39	WHITE	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	112	NA	112	NA	NA	0	112
TCGA-19-1789	NA	60	69	WHITE	FEMALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	Post-Adjuvant_Therapy	1	99	NA	99	NA	NA	0	99
TCGA-19-1790	NA	60	56	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	1	154	1	154	NA	NA	1	88
TCGA-19-1791	NA	NA	82	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	0	4	0	4	NA	NA	0	4
TCGA-19-2619	NA	40	55	BLACK_OR_AFRICAN_AMERICAN	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	0	294	0	294	NA	NA	1	146
TCGA-19-2620	NA	40	70	WHITE	MALE	Untreated_primary_de_novo_GBM	TUMOR_FREE	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	148	0	148	NA	NA	0	148
TCGA-19-2621	NA	NA	83	WHITE	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	NA	1	33	NA	33	NA	NA	0	33
TCGA-19-2623	NA	80	65	WHITE	MALE	Untreated_primary_de_novo_GBM	TUMOR_FREE	NA	NA	No	No	No	No	No	Post-Adjuvant_Therapy	0	229	0	229	NA	NA	0	229
TCGA-19-2624	NA	NA	51	WHITE	MALE	Untreated_primary_de_novo_GBM	TUMOR_FREE	NA	NA	No	No	No	No	No	NA	1	5	0	5	NA	NA	0	5
TCGA-19-2625	NA	NA	76	WHITE	FEMALE	Untreated_primary_de_novo_GBM	TUMOR_FREE	NA	NA	No	No	No	No	No	NA	1	124	0	124	NA	NA	0	124
TCGA-19-2629	NA	NA	60	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	737	1	737	NA	NA	1	145
TCGA-19-2631	NA	60	74	WHITE	FEMALE	Untreated_primary_de_novo_GBM	TUMOR_FREE	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	213	0	213	NA	NA	0	213
TCGA-19-4065	NA	NA	36	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	0	214	0	214	NA	NA	1	70
TCGA-19-4068	NA	80	68	WHITE	FEMALE	Untreated_primary_de_novo_GBM	TUMOR_FREE	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	0	137	0	137	NA	NA	0	137
TCGA-19-5947	NA	40	47	BLACK_OR_AFRICAN_AMERICAN	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	202	1	202	NA	NA	1	43
TCGA-19-5950	NA	100	52	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	Progressive_Disease	Uncomplete_Remission/Response	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	523	1	523	NA	NA	1	294
TCGA-19-5951	NA	80	76	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	244	1	244	NA	NA	1	244
TCGA-19-5952	NA	60	62	WHITE	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	575	NA	575	NA	NA	0	575
TCGA-19-5953	NA	NA	58	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	144	1	144	NA	NA	1	119
TCGA-19-5954	NA	60	72	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	Stable_Disease	Uncomplete_Remission/Response	No	No	No	No	No	Post-Adjuvant_Therapy	1	368	1	368	NA	NA	1	368
TCGA-19-5955	NA	NA	83	WHITE	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	NA	1	54	NA	54	NA	NA	0	54
TCGA-19-5956	NA	80	53	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	Stable_Disease	Uncomplete_Remission/Response	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	684	1	684	NA	NA	1	647
TCGA-19-5958	NA	80	56	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	Progressive_Disease	Uncomplete_Remission/Response	Recurrence	Yes	No	No	No	Post-Adjuvant_Therapy	1	428	1	428	NA	NA	1	356
TCGA-19-5959	NA	80	77	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	Progressive_Disease	Uncomplete_Remission/Response	Recurrence	Yes	No	No	No	Post-Adjuvant_Therapy	1	511	1	511	NA	NA	1	119
TCGA-19-5960	NA	80	56	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	Stable_Disease	Uncomplete_Remission/Response	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	455	1	455	NA	NA	1	382
TCGA-19-A60I	NA	NA	39	BLACK_OR_AFRICAN_AMERICAN	MALE	Glioblastoma_Multiforme_GBM	WITH_TUMOR	Stable_Disease	Uncomplete_Remission/Response	No	No	No	YES	YES	NA	0	541	0	541	NA	NA	0	541
TCGA-19-A6J4	NA	NA	68	BLACK_OR_AFRICAN_AMERICAN	MALE	Glioblastoma_Multiforme_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	121	1	121	NA	NA	1	121
TCGA-19-A6J5	0	100	40	BLACK_OR_AFRICAN_AMERICAN	MALE	Glioblastoma_Multiforme_GBM	WITH_TUMOR	Stable_Disease	Uncomplete_Remission/Response	Progression_of_Disease	Yes	No	YES	YES	Post-Adjuvant_Therapy	0	868	0	868	NA	NA	1	784
TCGA-26-1438	0	100	36	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	0	305	0	305	NA	NA	1	158
TCGA-26-1439	NA	NA	63	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	422	1	422	NA	NA	1	284
TCGA-26-1440	1	80	48	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	0	296	0	296	NA	NA	1	233
TCGA-26-1442	1	80	43	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Post-Adjuvant_Therapy	0	953	0	953	NA	NA	0	953
TCGA-26-1443	2	60	60	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Other	0	217	0	217	NA	NA	1	217
TCGA-26-1799	2	60	68	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	285	1	285	NA	NA	1	213
TCGA-26-5132	2	60	74	WHITE	MALE	Untreated_primary_de_novo_GBM	TUMOR_FREE	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	0	286	0	286	NA	NA	0	286
TCGA-26-5133	1	80	59	WHITE	MALE	Untreated_primary_de_novo_GBM	TUMOR_FREE	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	0	452	0	452	NA	NA	1	370
TCGA-26-5134	2	60	74	WHITE	MALE	Untreated_primary_de_novo_GBM	TUMOR_FREE	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	0	167	0	167	NA	NA	0	167
TCGA-26-5135	NA	NA	72	WHITE	FEMALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	NA	1	270	NA	270	NA	NA	0	270
TCGA-26-5136	NA	NA	78	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	577	1	577	NA	NA	1	577
TCGA-26-5139	2	60	65	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	0	48	0	48	NA	NA	0	48
TCGA-26-6173	1	80	57	WHITE	MALE	Untreated_primary_de_novo_GBM	TUMOR_FREE	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	0	241	0	241	NA	NA	0	241
TCGA-26-6174	1	80	65	WHITE	FEMALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	Post-Adjuvant_Therapy	0	71	0	71	NA	NA	0	71
TCGA-26-A7UX	NA	NA	47	BLACK_OR_AFRICAN_AMERICAN	MALE	Glioblastoma_Multiforme_GBM	WITH_TUMOR	Stable_Disease	Uncomplete_Remission/Response	Recurrence	Yes	No	YES	YES	NA	0	588	0	588	NA	NA	1	407
TCGA-27-1830	1	80	57	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Preoperative	1	154	1	154	NA	NA	1	124
TCGA-27-1831	1	80	66	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	505	1	505	NA	NA	1	144
TCGA-27-1832	0	100	59	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	300	1	300	NA	NA	1	176
TCGA-27-1833	1	80	67	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Preoperative	1	737	1	737	NA	NA	1	469
TCGA-27-1834	1	80	56	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	Pre-Adjuvant_Therapy	1	1233	1	1233	NA	NA	1	335
TCGA-27-1835	1	80	53	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	648	1	648	NA	NA	1	157
TCGA-27-1836	1	80	33	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	914	1	914	NA	NA	1	172
TCGA-27-1837	1	80	36	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	427	1	427	NA	NA	1	136
TCGA-27-1838	1	80	59	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	350	1	350	NA	NA	1	119
TCGA-27-2518	1	80	52	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	753	1	753	NA	NA	1	539
TCGA-27-2519	1	80	48	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	550	1	550	NA	NA	1	256
TCGA-27-2521	1	80	34	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	510	1	510	NA	NA	1	510
TCGA-27-2523	1	80	63	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	489	1	489	NA	NA	1	402
TCGA-27-2524	1	80	56	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	231	1	231	NA	NA	1	231
TCGA-27-2526	3	40	79	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	87	1	87	NA	NA	1	87
TCGA-27-2527	1	80	81	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	438	1	438	NA	NA	1	438
TCGA-27-2528	1	80	62	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	480	1	480	NA	NA	1	72
TCGA-28-1745	1	60	76	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	0	345	0	345	NA	NA	1	317
TCGA-28-1746	1	80	77	WHITE	FEMALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	0	6	0	6	NA	NA	0	6
TCGA-28-1747	NA	NA	44	WHITE	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	NA	1	77	NA	77	NA	NA	0	77
TCGA-28-1749	1	80	73	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	0	280	0	280	NA	NA	1	280
TCGA-28-1750	2	60	40	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	0	254	0	254	NA	NA	1	116
TCGA-28-1751	1	80	61	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	0	232	0	232	NA	NA	1	219
TCGA-28-1752	1	80	42	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Post-Adjuvant_Therapy	0	258	0	258	NA	NA	0	258
TCGA-28-1753	NA	NA	53	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	0	37	0	37	NA	NA	0	37
TCGA-28-1755	2	60	52	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Post-Adjuvant_Therapy	1	47	1	47	NA	NA	1	47
TCGA-28-1756	NA	80	78	WHITE	MALE	Untreated_primary_de_novo_GBM	TUMOR_FREE	NA	NA	No	No	No	No	No	Other	0	86	0	86	NA	NA	0	86
TCGA-28-1757	0	80	71	WHITE	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	0	4	0	4	NA	NA	0	4
TCGA-28-1760	NA	NA	48	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	0	143	0	143	NA	NA	1	105
TCGA-28-2499	NA	NA	59	WHITE	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	NA	0	95	NA	95	NA	NA	0	95
TCGA-28-2502	NA	20	65	WHITE	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	Post-Adjuvant_Therapy	0	20	0	20	NA	NA	0	20
TCGA-28-2506	NA	80	63	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	0	205	0	205	NA	NA	1	84
TCGA-28-2509	NA	80	77	WHITE	FEMALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	Post-Adjuvant_Therapy	0	145	0	145	NA	NA	0	145
TCGA-28-2512	1	90	37	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	343	1	343	NA	NA	1	193
TCGA-28-2513	NA	80	69	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	0	222	0	222	NA	NA	1	75
TCGA-28-2514	NA	60	45	ASIAN	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	Post-Adjuvant_Therapy	0	160	0	160	NA	NA	0	160
TCGA-28-5204	NA	80	72	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	454	1	454	NA	NA	1	454
TCGA-28-5207	NA	70	71	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	343	1	343	NA	NA	1	343
TCGA-28-5208	NA	70	52	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	Progressive_Disease	Uncomplete_Remission/Response	No	Yes	No	No	No	Pre-Adjuvant_Therapy	1	544	1	544	NA	NA	1	148
TCGA-28-5209	NA	NA	66	WHITE	FEMALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	NA	0	442	0	442	NA	NA	0	442
TCGA-28-5211	NA	100	42	BLACK_OR_AFRICAN_AMERICAN	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	Yes	No	No	No	Pre-Adjuvant_Therapy	0	358	0	358	NA	NA	1	225
TCGA-28-5213	NA	80	72	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	0	951	0	951	NA	NA	0	951
TCGA-28-5214	NA	70	53	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Locoregional_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	713	1	713	NA	NA	1	247
TCGA-28-5215	NA	90	62	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	Yes	No	No	No	Pre-Adjuvant_Therapy	1	335	1	335	NA	NA	1	164
TCGA-28-5216	NA	80	52	WHITE	MALE	Untreated_primary_de_novo_GBM	TUMOR_FREE	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	0	415	0	415	NA	NA	0	415
TCGA-28-5218	NA	NA	63	WHITE	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	NA	1	157	NA	157	NA	NA	0	157
TCGA-28-5219	NA	70	47	WHITE	FEMALE	Untreated_primary_de_novo_GBM	TUMOR_FREE	NA	NA	No	Yes	No	No	No	Pre-Adjuvant_Therapy	0	690	0	690	NA	NA	1	258
TCGA-28-5220	NA	90	67	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	Yes	No	No	No	Pre-Adjuvant_Therapy	1	388	1	388	NA	NA	1	262
TCGA-28-6450	NA	NA	60	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	165	1	165	NA	NA	1	165
TCGA-32-1970	1	NA	59	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	468	1	468	NA	NA	1	408
TCGA-32-1973	NA	NA	21	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	641	1	641	NA	NA	1	507
TCGA-32-1976	NA	60	65	WHITE	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	15	NA	15	NA	NA	0	15
TCGA-32-1977	NA	NA	63	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	0	3	0	3	NA	NA	0	3
TCGA-32-1978	NA	NA	57	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	482	1	482	NA	NA	1	482
TCGA-32-1979	NA	NA	69	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	593	1	593	NA	NA	1	265
TCGA-32-1980	NA	NA	72	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	36	1	36	NA	NA	1	36
TCGA-32-1982	NA	80	76	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	142	1	142	NA	NA	1	142
TCGA-32-1986	NA	20	68	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	1	386	1	386	NA	NA	1	233
TCGA-32-1987	NA	NA	49	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	452	1	452	NA	NA	1	68
TCGA-32-1991	NA	NA	60	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	515	1	515	NA	NA	1	345
TCGA-32-2491	NA	NA	63	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	372	1	372	NA	NA	1	70
TCGA-32-2494	NA	NA	58	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	632	1	632	NA	NA	1	488
TCGA-32-2495	NA	NA	59	WHITE	FEMALE	Treated_primary_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	Yes	No	No	NA	1	457	1	457	NA	NA	1	252
TCGA-32-2615	NA	80	62	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	485	1	485	NA	NA	1	131
TCGA-32-2616	1	NA	48	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	224	1	224	NA	NA	1	182
TCGA-32-2632	NA	NA	80	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	Progressive_Disease	Uncomplete_Remission/Response	No	No	No	No	No	NA	1	269	1	269	NA	NA	1	269
TCGA-32-2634	1	NA	82	WHITE	MALE	Untreated_primary_de_novo_GBM	TUMOR_FREE	NA	NA	No	No	No	No	No	NA	0	693	0	693	NA	NA	0	693
TCGA-32-2638	0	NA	67	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Pre-Adjuvant_Therapy	1	766	1	766	NA	NA	1	766
TCGA-32-4208	NA	NA	25	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	0	643	0	643	NA	NA	0	643
TCGA-32-4209	NA	NA	40	WHITE	MALE	Treated_primary_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	1	618	1	618	NA	NA	1	94
TCGA-32-4210	NA	NA	73	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	113	1	113	NA	NA	1	113
TCGA-32-4211	NA	NA	56	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	383	1	383	NA	NA	1	383
TCGA-32-4213	NA	NA	47	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Recurrence	Yes	No	No	No	NA	0	604	0	604	NA	NA	1	353
TCGA-32-4719	NA	NA	73	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	330	1	330	NA	NA	1	330
TCGA-32-5222	NA	NA	66	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	585	1	585	NA	NA	1	118
TCGA-41-2571	NA	60	89	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	26	1	26	NA	NA	1	26
TCGA-41-2572	1	NA	67	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	1	406	1	406	NA	NA	1	122
TCGA-41-2573	NA	60	59	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	0	272	0	272	NA	NA	1	167
TCGA-41-2575	NA	60	75	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	1	290	1	290	NA	NA	1	131
TCGA-41-3392	NA	NA	88	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	30	1	30	NA	NA	1	30
TCGA-41-3393	4	NA	81	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Post-Adjuvant_Therapy	1	135	1	135	NA	NA	1	135
TCGA-41-3915	1	NA	48	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Locoregional_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	360	1	360	NA	NA	1	288
TCGA-41-4097	NA	NA	63	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	6	1	6	NA	NA	1	6
TCGA-41-5651	1	NA	59	BLACK_OR_AFRICAN_AMERICAN	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Other	1	460	1	460	NA	NA	1	210
TCGA-41-6646	4	NA	73	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Other	1	379	1	379	NA	NA	1	200
TCGA-4W-AA9R	NA	NA	61	BLACK_OR_AFRICAN_AMERICAN	MALE	Glioblastoma_Multiforme_GBM	TUMOR_FREE	Progressive_Disease	Uncomplete_Remission/Response	No	No	No	No	No	NA	0	124	0	124	NA	NA	0	124
TCGA-4W-AA9S	NA	NA	69	BLACK_OR_AFRICAN_AMERICAN	MALE	Glioblastoma_Multiforme_GBM	TUMOR_FREE	Stable_Disease	Uncomplete_Remission/Response	No	No	No	YES	YES	NA	0	44	0	44	NA	NA	0	44
TCGA-4W-AA9T	1	70	54	BLACK_OR_AFRICAN_AMERICAN	FEMALE	Glioblastoma_Multiforme_GBM	TUMOR_FREE	Progressive_Disease	Uncomplete_Remission/Response	No	Yes	No	YES	YES	Post-Adjuvant_Therapy	0	778	0	778	NA	NA	1	749
TCGA-74-6573	NA	100	67	NA	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	105	1	105	NA	NA	1	105
TCGA-74-6575	NA	90	73	NA	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	Yes	No	No	No	Preoperative	0	636	0	636	NA	NA	1	93
TCGA-74-6577	NA	90	51	NA	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	Yes	No	No	No	Preoperative	0	132	0	132	NA	NA	1	132
TCGA-74-6578	NA	100	58	NA	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	Yes	No	No	No	Preoperative	0	436	0	436	NA	NA	1	222
TCGA-74-6581	NA	100	77	NA	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	0	250	0	250	NA	NA	0	250
TCGA-74-6584	NA	80	55	NA	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	Yes	No	No	No	Preoperative	0	228	0	228	NA	NA	1	91
TCGA-76-4925	0	100	76	WHITE	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	146	NA	146	NA	NA	1	88
TCGA-76-4926	NA	80	68	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	138	1	138	NA	NA	1	34
TCGA-76-4927	NA	80	58	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	535	1	535	NA	NA	1	416
TCGA-76-4928	NA	80	85	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	94	1	94	NA	NA	1	94
TCGA-76-4929	NA	80	76	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	111	1	111	NA	NA	1	111
TCGA-76-4931	NA	80	70	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	279	1	279	NA	NA	1	112
TCGA-76-4932	NA	80	50	WHITE	FEMALE	Treated_primary_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	1458	1	1458	NA	NA	1	1458
TCGA-76-4934	NA	80	66	WHITE	FEMALE	Untreated_primary_de_novo_GBM	TUMOR_FREE	NA	NA	No	No	No	No	No	NA	1	77	0	77	NA	NA	0	77
TCGA-76-4935	NA	80	52	WHITE	FEMALE	Untreated_primary_de_novo_GBM	TUMOR_FREE	NA	NA	No	No	No	No	No	NA	1	1121	0	1121	NA	NA	0	1121
TCGA-76-6191	1	80	57	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	1	508	1	508	NA	NA	1	323
TCGA-76-6192	1	80	74	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	100	1	100	NA	NA	1	76
TCGA-76-6193	NA	60	78	NA	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	Progression_of_Disease	Yes	No	No	No	NA	1	82	NA	82	NA	NA	1	64
TCGA-76-6280	1	80	57	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	1	346	1	346	NA	NA	1	108
TCGA-76-6282	1	80	63	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	519	1	519	NA	NA	1	458
TCGA-76-6283	NA	0	71	WHITE	FEMALE	Glioblastoma_Multiforme_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	165	1	165	NA	NA	1	165
TCGA-76-6285	NA	80	64	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	254	1	254	NA	NA	1	254
TCGA-76-6286	1	80	60	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	638	1	638	NA	NA	1	180
TCGA-76-6656	2	60	66	BLACK_OR_AFRICAN_AMERICAN	MALE	Untreated_primary_de_novo_GBM	NA	NA	NA	No	No	No	No	No	Preoperative	1	147	NA	147	NA	NA	0	147
TCGA-76-6657	1	80	74	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Preoperative	1	153	1	153	NA	NA	1	135
TCGA-76-6660	NA	0	73	WHITE	MALE	Glioblastoma_Multiforme_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	NA	1	114	1	114	NA	NA	1	114
TCGA-76-6661	2	60	54	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	727	1	727	NA	NA	1	727
TCGA-76-6662	1	80	58	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Post-Adjuvant_Therapy	1	1048	1	1048	NA	NA	1	205
TCGA-76-6663	1	80	44	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	1	567	1	567	NA	NA	1	567
TCGA-76-6664	1	80	49	WHITE	FEMALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Preoperative	0	1101	0	1101	NA	NA	0	1101
TCGA-81-5910	3	40	64	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	No	No	No	No	No	Other	1	49	1	49	NA	NA	1	49
TCGA-81-5911	1	NA	33	WHITE	MALE	Untreated_primary_de_novo_GBM	WITH_TUMOR	NA	NA	Progression_of_Disease	Yes	No	No	No	Pre-Adjuvant_Therapy	0	539	0	539	NA	NA	1	277
TCGA-87-5896	NA	NA	50	WHITE	FEMALE	Untreated_primary_de_novo_GBM	TUMOR_FREE	Complete_Remission/Response	Complete_Remission/Response	No	No	No	No	No	NA	0	800	0	800	0	800	0	800
TCGA-OX-A56R	NA	NA	68	BLACK_OR_AFRICAN_AMERICAN	MALE	Glioblastoma_Multiforme_GBM	WITH_TUMOR	Partial_Remission/Response	Uncomplete_Remission/Response	No	No	No	No	No	NA	1	180	1	180	NA	NA	1	180
TCGA-RR-A6KA	NA	NA	72	BLACK_OR_AFRICAN_AMERICAN	FEMALE	Glioblastoma_Multiforme_GBM	WITH_TUMOR	Partial_Remission/Response	Uncomplete_Remission/Response	No	No	No	NO	NO	NA	1	191	1	191	NA	NA	1	191
TCGA-RR-A6KB	NA	NA	51	BLACK_OR_AFRICAN_AMERICAN	MALE	Glioblastoma_Multiforme_GBM	NA	NA	NA	No	No	No	No	No	NA	0	0	0	0	NA	NA	0	0
TCGA-RR-A6KC	NA	NA	55	BLACK_OR_AFRICAN_AMERICAN	MALE	Glioblastoma_Multiforme_GBM	NA	Complete_Remission/Response	Complete_Remission/Response	Recurrence	Yes	No	YES	YES	NA	1	625	NA	625	1	369	1	369
